The FDA accepted an application for Padcev plus Keytruda for patients with muscle-invasive bladder cancer ineligible for ...

FOR countless people across Ireland, the simple act of laughing, coughing, or rushing for the bus comes with a hidden worry.

The tire curing bladder release agent market is poised for remarkable growth over the next decade, forecast to climb from USD ...

FDA prioritizes review of enfortumab vedotin and pembrolizumab for muscle-invasive bladder cancer, showing promising results in reducing recurrence and mortality.

Pfizer, Merck, AstraZeneca and Bristol Myers Squibb were among the many biopharmas showing off novel cancer modalities at ...

Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.

About 50% of menopausal women experience genitourinary syndrome of menopause (GSM) that involves changes to the genitals, ...

All that feed corn and all those soybeans—and those nearly 25 million hogs—produce a lot of nitrate. It’s making Iowans sick ...

Motorcycle backpacks might seem like your common schoolbag, but they're so much more. Check out these options if you're using ...

Big Spring, Texas / Syndication Cloud / October 14, 2025 / Wordsmith World Key Takeaways Physical benefits include the end of periods, with PMS symptoms and menstrual migraines often decreasing, ...

The portable ultrasound bladder scanner market is poised for significant growth due to rising urological disorders and advancements in imaging technology, including 3D scanning and AI integration.

The "Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2025" report highlights significant R&D opportunities with over 20 companies and 22 pipeline drugs, focusing on innovative treatments like ...